Table 4 Multiple regression analysis of the relationship between MMP2 and lung cancer
Variables (X) | Categories (different groups) | P value | OR value | 95% CI for OR | |
|---|---|---|---|---|---|
lower | upper | ||||
Gender (X1) | Male (X1–0) vs. female (X1–1) | 0.154 | 0.532 | 0.223 | 1.267 |
Age (X2) | < 60 (X2–0) vs. ≥60 (X2–1) | 0.618 | 0.808 | 0.422 | 1.671 |
Smoking (X3) | No (X3–0) vs. Yes (X3–2) | 0.558 | 0.810 | 1.401 | 1.637 |
Histology (X4) | LAC (X4–0) vs. LSCC (X4–1) vs. SCLC (X4–2) | 0.300 | 0.702 | 0.360 | 1.370 |
Differentiation (X5) | Poor (X5–0) vs. moderate (X5–1) vs. well (X5–2) | 0.633 | 0.620 | 0.704 | 1.781 |
Lymphatic invasion (X6) | N0-N1(X6–0) vs. N2-N3 (X6–1) | 0.540 | 0.485 | 0.048 | 4.919 |
T stage (X7) | T1-T2 (X7–0) vs. T3-T4 (X7–1) | 0.307 | 0.648 | 0.139 | 12.32 |
TNM (X8) | IIA - IIIA (X8–0) vs. IIIB - IV (X8–1) | 0.003 | 2.01 | 2.013 | 3.078 |
MMP2 (X9) | Low (X9–0) vs. moderate (X9–1) vs. high (X9–2) | 0.006 | 1.49 | 1.012 | 2.876 |
Risk function: | H(t) = [h0(t)] e (2.01 X8 + 1.49X9) | ||||